TYLE PRAVEEN has filed 8 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 30000 shares of KIORA PHARMACEUTICALS INC ($KPRX) on April 01, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2025 | KIORA PHARMACEUTICALS INC | $KPRX | TYLE PRAVEEN | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 3,000,788 | 9999.99% | 1.00% |
| Aug. 19, 2024 | KIORA PHARMACEUTICALS INC | $KPRX | TYLE PRAVEEN | Director | P | Common Stock | 5000 | $3.96 | 5,014.0000 | 2,970,545 | 9999.99% | 0.17% |
| July 1, 2024 | KIORA PHARMACEUTICALS INC | $KPRX | TYLE PRAVEEN | Director | A | Stock Option (right to buy) | 1778 | $0.00 | 1,778.0000 | 2,970,545 | 9999.99% | 0.06% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | TYLE PRAVEEN | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 7,006,038 | 9999.99% | 0.50% |
| Nov. 6, 2023 | Skye Bioscience, Inc. | $SKYE | TYLE PRAVEEN | Director | A | Stock Option (Right to Buy) | 14110 | $0.00 | 20,001.0000 | 0 | 239.52% | 0.00% |
| Aug. 25, 2023 | Skye Bioscience, Inc. | $SKYE | TYLE PRAVEEN | Director | A | Stock Option (Right to Buy) | 1472692 | $0.00 | 1,472,692.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | Skye Bioscience, Inc. | $SKYE | TYLE PRAVEEN | Director | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | Skye Bioscience, Inc. | $SKYE | TYLE PRAVEEN | Director | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |